Climb Bio Inc (CLYM) — Net Asset Quality Index
Climb Bio Inc (CLYM) has a Net Asset Quality Index of 97.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $246.29 Million minus total liabilities of $6.75 Million yields net assets of $239.55 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Climb Bio Inc for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Climb Bio Inc Net Asset Quality Index Over Time (2019–2025)
This chart shows how Climb Bio Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 97.3%, representing net assets of $239.55 Million against total assets of $246.29 Million USD. For live market cap and overall valuation, see CLYM market cap.
Annual Net Asset Quality Index for Climb Bio Inc (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Climb Bio Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Climb Bio Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.7% | $160.47 Million | $167.74 Million | $7.27 Million | ▼ -1.9 pp |
| 2024 | 97.6% | $211.88 Million | $217.19 Million | $5.31 Million | ▲ +0.2 pp |
| 2023 | 97.4% | $107.60 Million | $110.47 Million | $2.87 Million | ▲ +2.1 pp |
| 2022 | 95.4% | $128.72 Million | $134.99 Million | $6.28 Million | ▼ -1.2 pp |
| 2021 | 96.5% | $167.20 Million | $173.24 Million | $6.04 Million | ▲ +9.0 pp |
| 2020 | 87.6% | $21.57 Million | $24.63 Million | $3.06 Million | ▼ -8.8 pp |
| 2019 | 96.3% | $20.61 Million | $21.39 Million | $783.00K | — |